Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,013 results for ""Dyskinesias""

Your Filters

Subject : antiparkinson agents
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

New dopaminergic therapies for PD motor complications.

  • Authors : Larson D; Northwestern University Feinberg School of Medicine, Department of Neurology, United States. Electronic address: .; Simuni T

Subjects: Antiparkinson Agents/Antiparkinson Agents/Antiparkinson Agents/*therapeutic use ; Apomorphine/Apomorphine/Apomorphine/*therapeutic use ; Dopamine Agents/Dopamine Agents/Dopamine Agents/*therapeutic use

  • Source: Neuropharmacology [Neuropharmacology] 2022 Feb 15; Vol. 204, pp. 108869. Date of Electronic Publication: 2021 Nov 03.Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparing subjective and objective response to medications in Parkinson's disease patients using the Personal KinetiGraph™.

  • Authors : Krause E; UT MOVE, University of Texas Health Science Center at Houston Mc Govern Medical School, Houston, TX, USA.; Randhawa J

Subjects: Patient Reported Outcome Measures*; Accelerometry/Accelerometry/Accelerometry/*standards ; Antiparkinson Agents/Antiparkinson Agents/Antiparkinson Agents/*pharmacology

  • Source: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2021 Jun; Vol. 87, pp. 105-110. Date of Electronic Publication: 2021 May 11.Publisher: Elsevier Science Country of Publication: England NLM ID: 9513583 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Medical Management and Prevention of Motor Complications in Parkinson's Disease.

  • Authors : Aradi SD; Department of Neurology, Parkinson's Foundation Center of Excellence, University of South Florida, Tampa, FL, USA. .; Hauser RA

Subjects: Antiparkinson Agents/Antiparkinson Agents/Antiparkinson Agents/*administration & dosage ; Carbidopa/Carbidopa/Carbidopa/*administration & dosage ; Catechol O-Methyltransferase Inhibitors/Catechol O-Methyltransferase Inhibitors/Catechol O-Methyltransferase Inhibitors/*administration & dosage

  • Source: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2020 Oct; Vol. 17 (4), pp. 1339-1365.Publisher: Springer Country of Publication: United States NLM ID: 101290381 Publication Model: Print Cited Medium: Internet ISSN: 1878-7479

Record details

Read More Add to Saved list
×
Academic Journal

Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An update.

  • Authors : Leta V; King's College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, London, UK.; Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.

Subjects: Antiparkinson Agents/Antiparkinson Agents/Antiparkinson Agents/*administration & dosage ; Dyskinesias/Dyskinesias/Dyskinesias/*drug therapy ; Parkinson Disease/Parkinson Disease/Parkinson Disease/*drug therapy

  • Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2019 Dec; Vol. 18 (12), pp. 1203-1218. Date of Electronic Publication: 2019 Nov 05.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of Repeated Intravenous Amantadine Infusions in Patients with Parkinson's Disease: An Open-Label Pilot Study.

  • Authors : Khlebtovsky A; Department of Neurology, Rabin Medical Center - Beilinson Campus, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Subjects: Amantadine/Amantadine/Amantadine/*administration & dosage ; Antiparkinson Agents/Antiparkinson Agents/Antiparkinson Agents/*administration & dosage ; Dyskinesias/Dyskinesias/Dyskinesias/*drug therapy

  • Source: Clinical and translational science [Clin Transl Sci] 2019 Nov; Vol. 12 (6), pp. 586-590. Date of Electronic Publication: 2019 Sep 24.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson's Disease Patients.

Subjects: Activities of Daily Living* ; Outcome Assessment, Health Care* ; Quality of Life*

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2020; Vol. 10 (1), pp. 89-97.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium: Internet ISSN: 1877-718X

Record details

Read More Add to Saved list
×
Academic Journal

Improvement of dyskinesias with L-dopa infusion in advanced Parkinson's disease.

  • Authors : Timpka J; Department of Clinical Sciences, Neurology, Lund University, Lund, Sweden.; Fox T

Subjects: Antiparkinson Agents/Antiparkinson Agents/Antiparkinson Agents/*adverse effects ; Dyskinesias/Dyskinesias/Dyskinesias/*prevention & control ; Levodopa/Levodopa/Levodopa/*adverse effects

  • Source: Acta neurologica Scandinavica [Acta Neurol Scand] 2016 Jun; Vol. 133 (6), pp. 451-8. Date of Electronic Publication: 2015 Sep 11.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 0370336 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Editorial & Opinion

l-Dopa-free learned dyskinetic behavior in a Parkinson's primate model.

  • Authors : Li Q; Motac Neuroscience, UK-M15 6WE, Manchester, United Kingdom.; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China.

Subjects: Antiparkinson Agents/Antiparkinson Agents/Antiparkinson Agents/*adverse effects ; Conditioning, Psychological/Conditioning, Psychological/Conditioning, Psychological/*physiology ; Dyskinesia, Drug-Induced/Dyskinesia, Drug-Induced/Dyskinesia, Drug-Induced/*etiology

  • Source: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2019 Aug; Vol. 34 (8), pp. 1237. Date of Electronic Publication: 2019 May 13.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trials.

  • Authors : Pahwa R; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, 66160, USA. Electronic address: .; Isaacson S

Subjects: Activities of Daily Living* ; Outcome Assessment, Health Care*; Amantadine/Amantadine/Amantadine/*pharmacology

  • Source: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2019 Mar; Vol. 60, pp. 118-125. Date of Electronic Publication: 2018 Sep 05.Publisher: Elsevier Science Country of Publication: England NLM ID: 9513583 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A Transitional Probability Model for Parkinson's Disease Motor States With Applications to Missing Data.

  • Authors : Dinh P; 1 Castro Valley, CA, USA.

Subjects: Markov Chains* ; Models, Statistical*; Antiparkinson Agents/Antiparkinson Agents/Antiparkinson Agents/*administration & dosage

  • Source: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2019 Jul; Vol. 53 (4), pp. 420-425. Date of Electronic Publication: 2018 Sep 17.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,013 results for ""Dyskinesias""